SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 3 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,854 | +5.9% | 700 | 0.0% | 0.08% | +6.9% |
| Q2 2023 | $80,164 | -48.9% | 700 | -93.5% | 0.07% | -7.7% |
| Q3 2021 | $157,000 | +37.7% | 10,700 | 0.0% | 0.08% | +77.3% |
| Q2 2021 | $114,000 | -12.3% | 10,700 | 0.0% | 0.04% | -10.2% |
| Q1 2021 | $130,000 | -20.2% | 10,700 | -48.3% | 0.05% | -18.3% |
| Q4 2020 | $163,000 | +44.2% | 20,700 | 0.0% | 0.06% | +33.3% |
| Q3 2020 | $113,000 | -83.1% | 20,700 | +31.8% | 0.04% | -87.4% |
| Q1 2020 | $670,000 | -14.1% | 15,700 | 0.0% | 0.36% | -4.0% |
| Q4 2019 | $780,000 | – | 15,700 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
| Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
| NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
| Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
| RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
| Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
| Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
| Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |
| Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |